CDC advisory panel delays vote on hepatitis B vaccines
Digest more
For decades, newborns in the U.S. have been given the hepatitis B vaccine. This could change. A CDC vaccine advisory panel may vote to end that routine vaccination. Here's what parents should know.
A federal vaccine advisory committee this week is expected to discuss whether newborns should still get the hepatitis B vaccine — the first shot found to prevent cancer
Comments by President Trump, Health Secretary Robert F. Kennedy Jr. and some panelists suggest the committee is likely to delay hepatitis B shots and discuss revising the use of other vaccines.
Straight Arrow News on MSN
RFK Jr.’s vaccine advisers considering major overhaul of childhood immunization schedule
CDC advisers are set to vote on scrapping the hepatitis B birth dose, sparking warnings from experts about potential health risks.
Babies can contract Hepatitis B from their mothers during childbirth, even if the mother doesn’t know she’s infected. Infants who contract Hepatitis B during the first year of life have a 90% chance of developing lifelong chronic Hepatitis B infection.
Dr. Chari Cohen, President of the Hepatitis B Foundation, discusses the possible changes to the childhood vaccine schedule, delaying hepatitis B shots.